# Effect of Inhaled Ciclesonide in Adult Patients With Asthma (BY9010/M1-125)

> **NCT00546520** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 21 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Ciclesonide

## Key facts

- **NCT ID:** NCT00546520
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-04
- **Primary completion:** 2002-06
- **Final completion:** 2002-06
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2016-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00546520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00546520, "Effect of Inhaled Ciclesonide in Adult Patients With Asthma (BY9010/M1-125)". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00546520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*